twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2005
vol. 107
 
Share:
Share:
abstract:
Review paper

The role of anti-pericyte antibodies in the development of diabetic retinopathy

Joanna Adamiec
1
,
Jolanta Oficjalska-Młyńczak
1

  1. Katedra i Klinika Okulistyki Akademii Medycznej im. Piastów Śląskich we Wrocławiu
Klinika Oczna 2005, 107(7-9): 541-543
Online publish date: 2005/09/22
View full text Get citation
 
Diabetic retinopathy is one of the most common devastating complications of diabetes. Pericyte loss, microaneurysms and acellular capilllaries are characteristic for the diabetic retina. Researches have provided evidence that hyperglycaemia is one of the main factors driving the onset and progression of diabetic retinopathy. Although it has been shown that tight metabolic control has beneficial effects on the development and progression of this complication, the increase of blood glucose concentrations does not account for all the risk for development and progression to sight threatening retinopathy. A number of reports suggest that autoimmune mechanism play a role in diabetic microangiopathy (circulating antiendothelial cells autoantibodies, antiphospholipid antibodies, presence of immunoglobulins, lymphocytes and cytokines in diabetic retinal tissue). Diabetic subjects were also found to have autoantibodies to microvascular pericytes in their circulation. These results may contribute to understanding why retinopathy progresses in some patients, despite consistent reduction of blood sugar. This publication tries to estimate the anti-pericyte autoantibodies role in progression of diabetic retinopathy.
keywords:

pericytes, diabetic retinopathy, autoantobodies, capillaries

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.